- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Elranatamab, +19 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Phase 2
Explore clinical trials studying Phase 2. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Phase 2 trial results
NCT07283731
- Conditions
- Advanced/Metastatic, Neoplasm Metastasis, Neoplasms, +10 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum
NCT07511023
- Conditions
- Cell Carcinoma of the Anus/ Rectum, Neoplasm Metastasis, Neoplasms, +7 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphoma
NCT07783594
- Conditions
- Epcoritamab, Follicular Lymphoma, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial
NCT07610525
- Conditions
- Blood and Image Guided, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States